MedTrace Logo

Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury

NCT06043167 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-09-21

No results posted yet for this study

Summary

The aim of this study is to increase the effectiveness of clinical monitoring of patients with acute cerebral insufficiency by improving the discriminative ability of the FOUR scale. To study the sensitivity and specificity of the FOUR scale as a clinimetric of chronic disorders of consciousness.

Conditions

  • Stroke
  • Acute Traumatic Brain Injury
  • Subarachnoid Hemorrhage

Interventions

DIAGNOSTIC_TEST

The predictive value russian rendition the FOUR score.

It is planned to include at least 200 adult OAR patients and all those transferred to the rehabilitation department for evaluation. To maintain accounting documentation, an individual registration card is offered for registration. The paper version of the IRC records the age of the patient, the diagnosis according to the International Classification of diseases of the tenth revision (ICD-10), the day of hospital stay and ICU. The level of consciousness is assessed according to the unified interdisciplinary scale of disorders of consciousness, Glasgow Coma Scale (GCS), Full Outline of Unresponsiveness (FOUR) and Richmond Agitation-Sedation Scale (RASS). After each inspection, the data is entered into the electronic version of the IRC.

Sponsors & Collaborators

  • Ural State Medical University

    collaborator OTHER

  • Surgut Clinical Trauma Hospital

    lead OTHER

Principal Investigators

  • Andrey Belkin · Russian Federation of Anesthesiologists and Reanimatologists

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-08
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06043167 on ClinicalTrials.gov